PRGO Q3 2021 Earnings — Perrigo Company plc Revenue & Financial Results | Market Cap Arena

PRGOPerrigo Company plc

$1B

Q3 2021 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$1.0B+4.0% YoY

Gross Profit

$336M32.3% margin

Operating Income

$438M42.0% margin

Net Income

-$59M-5.6% margin

EPS (Diluted)

$-0.44

QoQ Revenue Growth

+6.3%

Cash Flow

Operating Cash Flow

$344M

Free Cash Flow

$302M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$10.9B

Total Liabilities

$5.7B

Stockholders' Equity

$5.2B

Cash & Equivalents

$2.1B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.0B	$1.0B	+4.0%
Gross Profit	$336M	$370M	-9.0%
Operating Income	$438M	$79M	+458.3%
Net Income	-$59M	-$155M	+61.9%

Revenue Segments

Consumer Self-Care Americas

$694M67%

Consumer Self-Care International

$349M33%

Geographic Segments

UNITED STATES

$657M63%

Europe

$335M32%

Other Geographical Areas

$51M5%

IRELAND

$8M1%